Peter D. Cole
-
- Childhood Cancer Survivors' Quality of Life 52
-
- Acute Lymphoblastic Leukemia research 69
- Genetics top 5%
-
- Lymphoma Diagnosis and Treatment 34
- Hematology top 5%
-
- Cancer-related cognitive impairment studies 24
- Lung Cancer Treatments and Mutations 10
-
- CNS Lymphoma Diagnosis and Treatment 11
-
- Adolescent and Pediatric Healthcare 10
-
- Folate and B Vitamins Research 9
- Co-authors
- Barton A. KamenKara M. KellyJudah FolkmanVeena VijayanathanLewis B. SilvermanRichard A. DrachtmanMaria GulinelloStephen E. Sallan
- Cited by
- Pediatrics, Perinatology and Child HealthPublic Health, Environmental and Occupational HealthGenetics
- Journals
- Blood (20 papers)Pediatric Blood & Cancer (15 papers)Journal of Clinical Oncology (12 papers)
- Partner nations
- United StatesCanadaPuerto Rico
In The Last Decade
Peter D. Cole
124 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 125
- Pediatrics, Perinatology and Child Health 827
- Public Health, Environmental and Occupational Health 915
- Genetics 301
- Pathology and Forensic Medicine 461
- Hematology 261
Countries citing papers authored by Peter D. Cole
This map shows the geographic impact of Peter D. Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Cole more than expected).
Fields of papers citing papers by Peter D. Cole
This network shows the impact of papers produced by Peter D. Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Cole. The network helps show where Peter D. Cole may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter D. Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 7 | |
| 13 | 2018 | 54 | |
| 14 | 2016 | 8 | |
| 15 | 2016 | 27 | |
| 16 | 2008 | 40 | |
| 17 | 2006 | 13 | |
| 18 | mTOR inhibition leads to increased sensitivity to methotrexate | 2005 | 3 |
| 19 | 2005 | 46 | |
| 20 | 1990 | 7 |
About Peter D. Cole
Peter D. Cole is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, Speech and Hearing and Pulmonary and Respiratory Medicine, having authored 135 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (69 papers), Childhood Cancer Survivors' Quality of Life (52 papers), Lymphoma Diagnosis and Treatment (34 papers), Cancer-related cognitive impairment studies (24 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Adolescent and Pediatric Healthcare (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Folate and B Vitamins Research (9 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (827 citations), Public Health, Environmental and Occupational Health (915 citations), Genetics (301 citations), Pathology and Forensic Medicine (461 citations) and Hematology (261 citations). Peter D. Cole has collaborated with scholars based in United States, Canada and Puerto Rico. Frequent co-authors include Barton A. Kamen, Kara M. Kelly, Judah Folkman, Veena Vijayanathan, Lewis B. Silverman, Richard A. Drachtman, Maria Gulinello, Stephen E. Sallan, Kristen E. Stevenson and Donna Neuberg. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.